Int'l sleep-aid mkt to touch $33 bn in 2014

The value of the international market for sleep aids is likely to leap from an estimated $25 billion in 2009 to more than $33 billion in 2014 ” for a 5-year compound annual growth rate (CAGR) of 5.8% ” a report issued by BCC Research has revealed. BCC Research (which examines major economic, scientific, and technological developments in industrial, pharmaceutical, and high technology organisations) has titled the report "Sleep Aids: Technologies and Global Markets'.

According to the report, the largest swath of the segment, mattresses and pillows, is expected to grow at a CAGR of 3.3%, shooting up to nearly $12.5 billion in 2014.

The second-largest segment, sleep laboratories, was pegged at $6.7 billion in 2009, and is predicted to rise at a 5-year CAGR of 6.5% to touch a mark higher than $9.2 billion in 2014.

The medications segment may overhaul the $7.7 billion mark in 2014, after rising at a CAGR of 8.3% from the 2009 value ($5.2 billion).

Sleep apnea devices, constituting the smallest segment, had a valuation of nearly $2.6 billion in 2009. It is forecast that the segment will rise to nearly $3.8 billion in 2014, fuelled by a CAGR of 7.8%.

The BCC Research report aims to accomplish a comprehensive study of sleep disorders and treatments. The methods used to treat the disorders are discussed in depth, and the market for the ameliorative offerings are analysed.